Medication info
Byterin Q Tablets 10/20mg

Byterin Q Tablets 10/20mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
YoungPoong Pharmaceuticals Co., Ltd.
Appearance
White to off-white, biconvex, rectangular tablet
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201900315 · Approved 2019.01.22 · Insurance code 661905140

Summary

Main use
Management of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dosage of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. The dosage range for this drug is 10/10mg~10/40mg once daily. The generally recommended starting dose is 10/20mg once daily. Patients who require only a modest reduction in LDL cholesterol may start with 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 10/80 mg is restricted to patients who have been taking this drug at 10/80 mg for 12 months or more without evidence of muscle toxicity, particularly during the first year of treatment (see “Warnings”). The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. No dosage adjustment is necessary in patients with mild hepatic impairment; however, this drug is not recommended for patients with moderate or severe hepatic impairment (see Precautions for Use, Section 5. General Precautions, Patients with Abnormal Liver Function). No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug at 10/20mg once daily in the evening. When administering higher doses of this drug to these patients, use caution and monitor them closely (see Precautions for Use, Section 5. General Precautions). No dosage adjustment is necessary in elderly patients. Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
YoungPoong Pharmaceuticals Co., Ltd.

Efficacy & effects

Management of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This drug is used primarily to reduce total cholesterol, LDL-cholesterol, apo B protein, and triglycerides, and to increase HDL-cholesterol levels in patients with primary hypercholesterolemia, both familial and non-familial, as well as mixed dyslipidemia. It can also be used as an adjunct to other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia or alone if other therapies are ineffective. This medication should be used in conjunction with an appropriate diet and is mainly administered when dietary and non-drug treatments alone are insufficient. Active lipid control is also required for patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia. Before administration, other causes of dyslipidemia should be identified and treated, and the therapeutic effect should be monitored with regular lipid tests. Thus, this drug effectively improves cholesterol and lipid levels, helping to prevent cardiovascular diseases.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dosage of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. The dosage range for this drug is 10/10mg~10/40mg once daily. The generally recommended starting dose is 10/20mg once daily. Patients who require only a modest reduction in LDL cholesterol may start with 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 10/80 mg is restricted to patients who have been taking this drug at 10/80 mg for 12 months or more without evidence of muscle toxicity, particularly during the first year of treatment (see “Warnings”). The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. No dosage adjustment is necessary in patients with mild hepatic impairment; however, this drug is not recommended for patients with moderate or severe hepatic impairment (see Precautions for Use, Section 5. General Precautions, Patients with Abnormal Liver Function). No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug at 10/20mg once daily in the evening. When administering higher doses of this drug to these patients, use caution and monitor them closely (see Precautions for Use, Section 5. General Precautions). No dosage adjustment is necessary in elderly patients. Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medication can cause muscle-related side effects such as myopathy or rhabdomyolysis. The risk may be higher, especially when taken at high doses or in combination with certain medications. Before taking this medication, individuals with allergic reactions or liver disease, as well as pregnant or breastfeeding women, should not use it. Additionally, it should not be co-administered with certain potent drugs. Caution should be exercised when administering this drug to patients with severe myasthenia or myalgia, and immediate consultation with a physician is required if these symptoms occur. It is advisable to undergo regular liver function tests while taking this medication, and use should be discontinued if there are abnormalities in liver function. This drug can interact with various other medications; therefore, inform your doctor or pharmacist if you are taking other medicines. Special caution is required when taken with certain antifungals, antibiotics, antivirals, and anticoagulants. Pregnant women or those planning to become pregnant should not take this medication, and if pregnancy is confirmed while taking it, immediate discontinuation and a consultation with a physician are necessary. Breastfeeding women should also discontinue breastfeeding while on this medication for safety. Safety in children and adolescents has not been sufficiently established, so it is not recommended for children under 10 years old. Elderly patients require special attention, and monitoring is necessary due to the possibility of adverse reactions. In case of overdose, since there are no specific antidotes, appropriate treatment according to symptoms is essential. If unexplained muscle pain or weakness occurs during treatment, inform healthcare providers immediately, and it is safe to check muscle status and liver function through regular blood tests.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, paresthesia, depression, cholelithiasis, cholecystitis, skin mucosal syndrome, toxic epidermal necrolysis, eosinophilia, drug reactions with systemic symptoms, erythema multiforme, myasthenia, cataract, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, oculomotor dysfunction, facial paresis, tremors, peripheral neuropathy, peripheral nerve paralysis, psychiatric disorders, anxiety, sleep disorders, cognitive decline, forgetfulness, amnesia, memory disturbances, confusion, interstitial lung disease, lupus erythematosus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibodies, increased erythrocyte sedimentation rate, arthritis, fever, chills, flushing, malaise, dyspnea, gallbladder stasis jaundice, hepatic steatosis, cirrhosis, fulminant hepatic necrosis, liver cancer, liver failure, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ophthalmoplegia, anemia, elevated aminotransferases, increased ALP, elevated gamma-GT, increased bilirubin, thyroid dysfunction, elevated serum creatine kinase, transient liver function test abnormalities, increased HbA1c, increased fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 degree and 30 degrees Celsius at room temperature. This helps maintain the drug's efficacy and prevents deterioration.

Appearance and packaging

Appearance

White to off-white, biconvex, rectangular tablet

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.